It is well established that portal hypertension can occur in the absence of cirrhosis, as
reported in patients with immune disorders, infections and thrombophilia. However, similar …

Portal vein thrombosis unrelated to solid malignancy is common in patients with cirrhosis,
but less frequently observed in patients without cirrhosis. Prompt diagnosis and …

Portal hypertension in the absence of portal vein thrombosis and without cirrhosis, but with
mild or moderate alterations of liver histology (eg, obliterative venopathy, nodular …

The incidence of esophageal adenocarcinoma (EAC) has increased in recent decades, and
its 5-year survival rate is less than 20%. As a well-established precursor, patients with …

Portal hypertension and bleeding from gastroesophageal varices is the major cause of
morbidity and mortality in patients with cirrhosis. Portal hypertension is initiated by increased …

The trans jugular intrahepatic Porto systemic shunt (TIPS) is no longer viewed as a salvage
therapy or a bridge to liver transplantation and is currently indicated for a number of …

Idiopathic non-cirrhotic portal hypertension (INCPH) is a rare disease characterized of
intrahepatic portal hypertension in the absence of cirrhosis or other causes of liver disease …

Background Idiopathic portal hypertension (IPH) and extrahepatic portal venous obstruction
(EHPVO) are non-cirrhotic vascular causes of portal hypertension (PHT). Variceal bleed and …

With advances in the management and treatment of advanced liver disease, including the
use of antiviral therapy, a simple, one stage description for advanced fibrotic liver disease …

Idiopathic noncirrhotic portal hypertension is a heterogeneous group of diseases
characterized by portal hypertension in the absence of cirrhosis. The efficacy and safety of …